The downregulation of MFN2 is partly attributed to the decreased expression of the peroxisome proliferator-activated receptor alpha (PPARα) caused by the lipid metabolism disorder in DCM [49] (Figure 2(b)). The gene discussed is MFN2; the disease is familial dilated cardiomyopathy.